NRF2/KEAP1 and Wnt/β-catenin in the multistep process of liver carcinogenesis in humans and rats

Hepatology

Volumn 62, Issue 3, 2015, Pages 677-679

  Nault, Jean Charles ^a,b,c,d   Rebouissou, Sandra ^a,b,c   Zucman Rossi, Jessica ^a,b,c,e  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c UNIVERSITÉ PARIS 13   (France)

^d ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^e HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; KELCH LIKE ECH ASSOCIATED PROTEIN 1; TRANSCRIPTION FACTOR NRF2; WNT PROTEIN; GA BINDING PROTEIN;

ARTICLE; BINDING SITE; GENE ACTIVATION; HUMAN; LIVER CARCINOGENESIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SOMATIC MUTATION; ANIMAL; CARCINOGENESIS; EXPERIMENTAL LIVER NEOPLASM; GENETICS; LIVER CELL CARCINOMA; MALE; MUTATION;

ANIMALS; CARCINOGENESIS; CARCINOMA, HEPATOCELLULAR; GA-BINDING PROTEIN TRANSCRIPTION FACTOR; HUMANS; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MUTATION;

EID: 84939603190     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.27828     Document Type: Article

References (10)

1. Schulze K, Imbeaud S, Letouze E, Alexandrov LB, Calderaro J, Rebouissou S, et al. Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets. Nat Genet 2015 Mar 30. doi: 10.1038/ng.3252. [Epub ahead of print]
2. Guichard C, Amaddeo G, Imbeaud S, Ladeiro Y, Pelletier L, Maad IB, et al. Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nat Genet 2012;44:694-698.
3. Totoki Y, Tatsuno K, Covington KR, Ueda H, Creighton CJ, Kato M, et al. Trans-ancestry mutational landscape of hepatocellular carcinoma genomes. Nat Genet 2014;46:1267-1273.
4. Sporn MB, Liby KT. NRF2 and cancer: the good, the bad and the importance of context. Nat Rev Cancer 2012;12:564-571.
5. Ramos-Gomez M, Kwak MK, Dolan PM, Itoh K, Yamamoto M, Talalay P, Kensler TW. Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice. Proc Natl Acad Sci U S A 2001;98:3410-3415.
6. Eichenmuller M, Trippel F, Kreuder M, Beck A, Schwarzmayr T, Haberle B, et al. The genomic landscape of hepatoblastoma and their progenies with HCC-like features. J Hepatol 2014;61:1312-1320.
7. DeNicola GM, Karreth FA, Humpton TJ, Gopinathan A, Wei C, Frese K, et al. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature 2011;475:106-109.
8. Zavattari P, Perra A, Menegon S, Kowalik L, Petrelli A, Angioni M, et al. Nrf2, but not β-catenin, mutation represents an early event in rat hepatocarcinogenesis. Hepatology 2015;62:851-862.
9. Nault JC, Mallet M, Pilati C, Calderaro J, Bioulac-Sage P, Laurent C, et al. High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions. Nat Commun 2013;4:2218.
10. Nault JC, Calderaro J, Di Tommaso L, Balabaud C, Zafrani ES, Bioulac-Sage P, et al. Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis. Hepatology 2014;60:1983-1992.